Guidelines for pain and sedation in ECMO patients
Part of Brain & nervous system, Heart & circulation, Lungs & breathing clinical trials.
This study tests a standard set of rules for giving pain and sedation medications to adults on ECMO. The aim is to see if these guidelines are practical and help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must be on ECMO (a heart-lung support machine).
- You must be receiving pain or sedation medication through a continuous IV drip.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new sedation protocol for adults in intensive care who need strong pain relief or sedation medicines. It aims to make sedation safer and more comfortable, and includes people on ECMO (a heart-lung machine) or a ventilator (breathing machine) for severe breathing problems.
This study asks ICU nurses about sedation and pain management practices. It aims to understand current approaches and improve patient care.
This study measures how sedating and pain medicines move through the body in children who are supported by ECMO (a heart-lung machine). It may help doctors choose safer and more effective dosing for sedation and pain control during ECMO.
This study surveys emergency doctors, nurses, and patients to understand how pain relief and sedation are managed. It aims to improve care in emergency resuscitation rooms.
This study tests an inhaled sedative called isoflurane to keep patients calm while on a breathing machine and ECMO for severe heart failure. It may be an alternative to standard IV sedatives.
This study tests a new way to manage pain and sedation for people on breathing machines in the ICU. It compares a personalized plan to usual care to see if it improves pain relief and recovery.
Hear when a new Intensive Care (ICU) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.